14.05.2013 Views

Book of Medical Disorders in Pregnancy - Tintash

Book of Medical Disorders in Pregnancy - Tintash

Book of Medical Disorders in Pregnancy - Tintash

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

the efficiency <strong>of</strong> this immune globul<strong>in</strong><br />

<strong>in</strong>cluded limited follow up period <strong>of</strong> 72<br />

hours only.<br />

Prognosis:<br />

Toxic levels <strong>of</strong> bilirub<strong>in</strong> can cause<br />

damage when it passes from the serum<br />

<strong>in</strong>to the basal ganglion cells <strong>of</strong> the bra<strong>in</strong>.<br />

Neurosensory hear<strong>in</strong>g loss is the most<br />

common sequela <strong>of</strong> excessive serum<br />

bilirub<strong>in</strong>. Kernicterus is a cl<strong>in</strong>ical<br />

syndrome where deposition <strong>of</strong> unconjugated<br />

bilirub<strong>in</strong> <strong>in</strong> certa<strong>in</strong> nuclei <strong>of</strong> the<br />

bra<strong>in</strong>, affects central nervous system.<br />

The album<strong>in</strong> b<strong>in</strong>d<strong>in</strong>g capacity is decreased<br />

<strong>in</strong> conditions where there is<br />

acidosis or history <strong>of</strong> Sulpho amide adm<strong>in</strong>istration<br />

and or where free fatty acid<br />

levels are elevated.<br />

These conditions predispose the neonate<br />

to Kernicterus even with lower levels <strong>of</strong><br />

bilirub<strong>in</strong>.<br />

The baby, who develops kernicterus,<br />

suddenly becomes lethargic and stops feed<strong>in</strong>g.<br />

His cry becomes high pitched. The<br />

respiratory rate becomes slow. Apnea,<br />

respiratory, arrest, and even convulsions<br />

may occur <strong>in</strong> severe cases. Infants who<br />

survive, have severe motor impairment,<br />

<strong>in</strong>clud<strong>in</strong>g hypotonia, spasticity, and<br />

athetosis.<br />

Mental retardation may occur but it is<br />

generally less severe. In term<strong>in</strong>al stages,<br />

the babies have irregular gasp<strong>in</strong>g<br />

respirations, bloody discharge from the<br />

nose and mouth. Most babies die with<strong>in</strong><br />

48 to 72 hours.<br />

Mortality or morbidity: Unlike<br />

unconjugated bilirub<strong>in</strong>, conjugated<br />

134<br />

bilirub<strong>in</strong> does not b<strong>in</strong>d significantly to<br />

neural tissue and does not lead to<br />

kernicterus or other forms <strong>of</strong> toxicity.<br />

• The morbidity and mortality associated<br />

with conjugated hyperbilirub<strong>in</strong>emia<br />

result from the under-ly<strong>in</strong>g<br />

disease process.<br />

In certa<strong>in</strong> disease states, such as<br />

alcoholic hepatitis or primary biliary<br />

cirrhosis, bilirub<strong>in</strong> levels correlate<br />

strongly with, but do not contribute to,<br />

short term mortality.<br />

The Group "0" rhesus negative packed<br />

cells should be cross mulched and found<br />

compatible with mother's blood. The<br />

hemoglob<strong>in</strong> <strong>in</strong> these cells should be<br />

around 26 to 28 gram per 100 ml and<br />

hematocrit <strong>of</strong> 85 to 95 per cent.<br />

The second transfusion could be given<br />

after 10 days and the 3rd and 4th with<strong>in</strong><br />

3 to 4 weeks <strong>in</strong>terval from the second.<br />

Delivery should be conducted around 34<br />

to 35 weeks.<br />

If on x-ray hydropic fetus with<br />

ascites is found then ascitic fluid is<br />

withdrawn first and mother is given<br />

digitalis and diuretic.<br />

Risks <strong>of</strong> <strong>in</strong>trauter<strong>in</strong>e transfusion:<br />

Only 45% <strong>of</strong> <strong>in</strong>trauter<strong>in</strong>e transfused<br />

babies are born alive and one third<br />

actually survive.<br />

The risk <strong>of</strong> immediate death after first<br />

<strong>in</strong>trauter<strong>in</strong>e transfusion is around 10 to<br />

12 per cent and another extra 5 per cent<br />

with each successive transfusion. The<br />

overall risk is around 7 per cent.<br />

Neonatal death rate <strong>in</strong> these babies is<br />

around 8 per cent.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!